The Better Lesional Site Identification (BLSi) quality improvement initiative was launched in the fall of 2020 at the University of California, San Francisco Department of Dermatology.
Our goal is to prevent wrong site surgery via high-quality biopsy site photos. We define high-quality biopsy site photos as including:
- discrete marking of the lesion
- one zoomed-in photo, and
- one zoomed-out photo with one or more anatomic landmarks.
In addition to developing concrete photography standards, we developed a clinical workflow for biopsy site photography, created visual aids for clinical work spaces and educated staff, trainees and faculty on the definition and process to obtain high-quality photos.
Our goal is to increase the percentage of photography to over 90% for all clinical biopsies and to increase the percentage of high-quality photos to 75% (pre-intervention 26%).
